This inventor holds 5 USPTO granted patents and 10 published patent applications. Top assignee: University of California. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2024
Title: Innovations and Contributions of Inventor Lars Bode
Introduction
Lars Bode is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of medical research, particularly in the area of liver disease and cardiovascular health. With a total of 5 patents, Bode's work has the potential to impact therapeutic approaches in these critical health areas.
Latest Patents
One of Lars Bode's latest patents is focused on the use of oligosaccharides as a therapeutic agent for alcohol-associated liver disease. This patent discloses methods and compositions for treating liver disease by administering 2′-FL to a subject. Another notable patent involves methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides. This disclosure provides therapies and methods to treat these conditions with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
Career Highlights
Lars Bode is affiliated with the University of California, where he conducts his research and develops innovative solutions to pressing health issues. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Lars Bode collaborates with esteemed colleagues, including Xi Chelsea Chen and Hai Yu. Their combined expertise enhances the research efforts and broadens the scope of their innovative projects.
Conclusion
Lars Bode's contributions to medical research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic strategies that could significantly benefit patients suffering from liver disease and cardiovascular conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
